Remedium Lifecare Limited (BOM:539561)

Market Cap	399.17M
Revenue (ttm)	5.27B
Net Income (ttm)	122.54M
Shares Out	403.20M
EPS (ttm)	0.19
PE Ratio	5.29
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,514,171
Average Volume	12,822,020
Open	1.0200
Previous Close	1.0100
Day's Range	0.9800 - 1.0200
52-Week Range	0.8000 - 6.1300
Beta	1.38
RSI	22.37
Earnings Date	Nov 14, 2025

About Remedium Lifecare

Remedium Lifecare Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium met...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539561

Financial Performance

In 2024, Remedium Lifecare's revenue was 4.05 billion, a decrease of -89.97% compared to the previous year's 40.42 billion. Earnings were 21.29 million, a decrease of -93.49%.